Ocular Regenerative Medicine Institute

 

Leading the effort to develop revolutionary methods to regenerate eye tissues for various diseases, including age-related macular degeneration (AMD), glaucoma, corneal disease, and ocular cancer.

Harvard Ophthalmology Ocular Regenerative Medicine Institute

CO-DIRECTORS
Demetrios G. Vavvas, MD, PhD
Michael J. Young, PhD
MEMBERS
See a list of ORMI faculty

Tissue and stem cell therapies hold enormous promise for repairing ocular tissues. Our investigators lead the effort to develop revolutionary methods to regenerate eye tissues for various diseases, including age-related macular degeneration (AMD), glaucoma, corneal disease, and ocular cancer. They significantly advanced the understanding of tissue and stem cell transplantation in the retina—particularly in terms of graft survival and the formation of functional neural connections after transplantation. Our investigators are also developing biomaterials that can be used for delivering neuroprotective agents or stem cells to the retina; the engineered biomaterials have also been shown to promote survival and functional growth of neurons after transplantation.

Featured Event

Biennial International Symposium on Ocular Regeneration
Save the Date: October 11, 2018 | Boston, MA
This meeting brings together thought leaders in the field to discuss the latest advances and the potential future of retinal regeneration. Learn more...

Featured News

Symposium on Ocular Regeneration

Investigators Share Research and Potential Applications for Eye Diseases at Ocular Regeneration Symposium

November 3, 2016

The second Biennial International Symposium on Ocular Regeneration brought together leaders in the fields of ophthalmology, genetics, stem cell biology, neuroregeneration, and neuroremodeling who aim to accelerate cures for blinding diseases. The event, held October 20, 2016 in Boston, MA, drew nearly 200 researchers, clinicians, trainees, and industry representatives from around the world.

New Grant for Retinal Tissue Engineering Awarded by the Bertarelli Program in Translational Neuroscience and Neuroengineering

New Grant for Retinal Tissue Engineering Awarded by the Bertarelli Program in Translational Neuroscience and Neuroengineering

October 24, 2014

OCTOBER 24, 2014 (Boston, MA): The Bertarelli Program in Translational Neuroscience and Neuroengineering a collaborative program between Harvard Medical School and the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, has announced a new set of grants worth $3.6 million for five research projects. This is a further strengthening of the partnership between Harvard and Swiss scientists begun in 2010.